EE227 Healthcare Resource Utilization and Costs Among Patients with Moderately-to-Severely Active Crohn’s Disease Treated with Ustekinumab: Real-World Evidence
Abstract
Authors
T Bessissow N Narula C Ma TSH In M Eberg E Pone V Jairath